Helicobacter pylori eradication with either quadruple regimen with lactoferrin or levofloxacin-based triple therapy: A multicentre study

This publication has 35 references indexed in Scilit:

• Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report
  Gut, 2007
• Primary clarithromycin resistance in Italy assessed on Helicobacter pylori DNA sequences by TaqMan real‐time polymerase chain reaction
  Alimentary Pharmacology & Therapeutics, 2006
• Twice-Daily Standard Dose of Omeprazole Achieves the Necessary Level of Acid Inhibition for Helicobacter pylori Eradication. A Randomized Controlled Trial Using Standard and Double Doses of Omeprazole in Triple Therapy
  Digestive Diseases and Sciences, 2005
• H pylori antibiotic resistance: prevalence, importance, and advances in testing
  Gut, 2004
• Low eradication rate ofHelicobacter pyloriwith triple 7-14 days and quadriple therapy in Turkey
  World Journal of Gastroenterology, 2004
• Maastricht II treatment scheme and efficacy of different proton pump inhibitors in eradicatingHelicobacter pylori
  World Journal of Gastroenterology, 2004
• Primary and secondary antibiotic resistance of Helicobacter pylori strains isolated in central Italy during the years 1998–2002
  Digestive and Liver Disease, 2003
• A systematic comparison of triple therapies for treatment of Helicobacter pylori infection with proton pump inhibitor/ ranitidine bismuth citrate plus clarithromycin and either amoxicillin or a nitroimidazole
  Alimentary Pharmacology & Therapeutics, 2001
• A meta‐analysis of short versus long therapy with a proton pump inhibitor, clarithromycin and either metronidazole or amoxycillin for treating Helicobacter pylori infection
  Alimentary Pharmacology & Therapeutics, 2000
• Evaluation of treatment regimens to cure Helicobacter pylori infection—a meta‐analysis
  Alimentary Pharmacology & Therapeutics, 1999